TP53 and cancer: Potent dual L peptide inhibitor PMI (TSFAEYWNLLSP) of p53-mdm2/mdmx interactions, encapsulated in a liposome, has a significant antitumor effect by inducing apoptosis and decreasing the synthesis phase of the cell cycle in U87 cancer cells.